Hide metadata

dc.date.accessioned2020-01-10T20:31:43Z
dc.date.available2020-01-10T20:31:43Z
dc.date.created2018-09-25T09:28:43Z
dc.date.issued2018
dc.identifier.citationVirto, Leire Cano, Pilar Jiménez-ortega, Vanesa Fernández-mateos, Pilar González, Jerián Haugen, Håvard Jostein Esquifino, Ana isabel Sanz Alonso, Mariano . Melatonin as adjunctive therapy in the treatment of periodontitis associated with obesity. Journal of Clinical Periodontology. 2018, 45(11), 1336-1346
dc.identifier.urihttp://hdl.handle.net/10852/72092
dc.description.abstractAims To study the effect of adjunctive systemic administration of melatonin to standard mechanical periodontal therapy in obese rats with experimental periodontitis. Materials and methods In 42 Wistar rats with an initial body weight of 180 g., half (n=21) were fed with a high‐fat diet to induce obesity. In both obese and normal‐weight groups, experimental periodontitis was subsequently induced through oral gavages with a combination of Porphyromona gingivalis and Fusobacterium nucleatum. Both groups were randomly allocated to either, no treatment or periodontal treatment consisting on standard mechanical debridement, with either adjunctive chlorhexidine or melatonin. Outcomes were evaluated by the changes in clinical parameters (probing depth modified gingival index, plaque dental index and bleeding on probing), in bone resorption and in the levels of biomarkers in plasma and in gingival tissue (inflammatory cytokines, insulin, leptin, osteocalcin, osteopontin, plasminogen activator inhibitor‐1, intercellular adhesion molecule 1, E‐selectin and lipids). Results In the obese‐periodontitis group, adjunctive melatonin administration resulted in reduced gingival inflammation and bleeding on probing, with significant reductions in probing depth and enhanced bone repair demonstrated by Micro‐CT (15% reduction in alveolar bone destruction) when compared with the same group treated with adjunctive CHX or the normal‐weight rats with either melatonin or CHX. In this melatonin‐treated obese‐periodontitis group, a significant impact on biochemical biomarkers was also demonstrated in both gingival and plasma samples, when compared with the other groups, with significant reductions in pro‐inflammatory cytokines. Conclusions Adjunctive melatonin therapy significantly reduced alveolar bone loss and exerted a protective anti‐inflammatory effect mainly in those experimental animals affected by the co‐morbidity of periodontitis and obesity.
dc.description.abstractMelatonin as adjunctive therapy in the treatment of periodontitis associated with obesity
dc.languageEN
dc.publisherMunksgaard Forlag
dc.titleMelatonin as adjunctive therapy in the treatment of periodontitis associated with obesity
dc.typeJournal article
dc.creator.authorVirto, Leire
dc.creator.authorCano, Pilar
dc.creator.authorJiménez-ortega, Vanesa
dc.creator.authorFernández-mateos, Pilar
dc.creator.authorGonzález, Jerián
dc.creator.authorHaugen, Håvard Jostein
dc.creator.authorEsquifino, Ana isabel
dc.creator.authorSanz Alonso, Mariano
cristin.unitcode185,16,17,62
cristin.unitnameBiomaterialer
cristin.ispublishedtrue
cristin.fulltextpreprint
cristin.qualitycode2
dc.identifier.cristin1613207
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Journal of Clinical Periodontology&rft.volume=45&rft.spage=1336&rft.date=2018
dc.identifier.jtitleJournal of Clinical Periodontology
dc.identifier.volume45
dc.identifier.issue11
dc.identifier.startpage1336
dc.identifier.endpage1346
dc.identifier.doihttps://doi.org/10.1111/jcpe.13013
dc.identifier.urnURN:NBN:no-75204
dc.subject.nviVDP::Periodonti: 837
dc.type.documentTidsskriftartikkel
dc.source.issn0303-6979
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/72092/4/Leire%2BArt3%2Bv14LV.pdf
dc.type.versionSubmittedVersion


Files in this item

Appears in the following Collection

Hide metadata